BMC2 Executive Board

The BMC2 Executive Board brings together internationally recognized experts who support the consortium by elevating the data, people, and BMC2 mission for purposeful impact.
Rasha Al-Lamee, MA, MBBS, FRCP, PhD
Interventional Cardiology Consultant
Imperial College Healthcare NHS Trust, London, UK
Professor of Cardiology
National Heart and Lung Institute within Imperial College London, UK
Professor Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College

 

David J. Cohen, MD, MSc
Director of Clinical and Outcomes Research
Cardiovascular Research Foundation, New York, NY
Director of Academic Affairs
St. Francis Hospital, Roslyn, NY
James Grant, MD, MBA, FASA

Anesthesiologist

Corewell Health William Beaumont University Hospital, Royal Oak, MI

Clinical Professor

Oakland University William Beaumont School of Medicine, Rochester, MI

Emeritus Executive Vice President, Clinical Affairs and Chief Medical Officer

Blue Cross Blue Shield of Michigan

Hitinder Gurm, MD
BMC2 Executive Board Chair
Professor of Internal Medicine, U-M Health, Ann Arbor, MI

Chief Medical Officer, U-M Health, Ann Arbor, MI
Caitlin W. Hicks, MD, MS
Vice Chair of Research, Department of Surgery
Associate Professor of Surgery
Johns Hopkins University School of Medicine, Baltimore, MD
Sunil V. Rao, MD, FACC, FSCAI
Professor of Medicine
NYU Grossman School of Medicine, New York, NY
Division Director
Leon H. Charney Division of Cardiology, NYU Langone Health System, New York, NY

Executive Board Purpose:

  • Strategic Leadership
  • Collaborative Engagement
  • Policy Development and National Impact
  • Innovation Advancement
  • Communication
  • ROI

The team strongly believes in BMC2’s vision to steadily impact Michigan’s and the United States’ number one health problem, cardiovascular disease, and brings broad diversity in background, interest, experience, and leadership. 

Meetings are held twice yearly: one virtual meeting and one in-person meeting, alongside a national meeting.